49 participants
Daratumumab, Ixazomib, & Dexamethasone or Daratumumab, Bortezomib, & Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-06-21
- Start Date:
- 2019-07-03
- Completion:
- 2025-07-31
Conditions
- Plasma Cell Myeloma
Interventions
- DRUG
- BIOLOGICAL
No Results Yet